Optimizing target-organ protection in patients with diabetes mellitus: Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers? Wei X. LuJay LakkisMatthew R. Weir OriginalPaper Pages: 192 - 198
Potential mechanisms of impaired endothelial function in arterial hypertension and hypercholesterolemia Stefan JohnRoland E. Schmieder OriginalPaper Pages: 199 - 207
Oxidative stress and heart disease: Cardiac dysfunction, nutrition, and gene therapy Elliott J. F. CantorEnrico V. ManciniThomas Netticadan OriginalPaper Pages: 215 - 220
Are β-blockers efficacious as first-line therapy for hypertension in the elderly? Konrad Wink OriginalPaper Pages: 221 - 224
The renin-angiotensin system in blacks: Active, passive, or what? Deborah A. PriceNaomi D. L. Fisher OriginalPaper Pages: 225 - 230
Are low target blood pressure goals justified in persons with diabetes mellitus? Errol D. CrookLatha Velusamy OriginalPaper Pages: 231 - 238
Effects of hormone replacement therapy on the sympathetic nervous system and blood pressure J. Michael WyssScott H. Carlson OriginalPaper Pages: 241 - 246
Hypertension and cognitive function: Pathophysiologic effects of hypertension on the brain Teri A. ManolioJean OlsonW. T. Longstreth Jr OriginalPaper Pages: 255 - 261
Brainstem mechanisms of hypertension: Role of the rostral ventrolateral medulla Alan F. SvedSatoru ItoJudith C. Sved OriginalPaper Pages: 262 - 268
The role of the sympathetic nervous system in linking obesity with hypertension in white versus black Americans Pirooz EslamiMichael Tuck OriginalPaper Pages: 269 - 272